EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement

Kashish Goel, JoAnn Lindenfeld, Pradeep Yadav, Rebecca T Hahn, Mayra E Guerrero, Scott Chadderdon, Rahul P Sharma, Robert Smith, Vinod Thourani, Mackram F Eleid, Charles J Davidson, Colin Barker und 2 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.04.034 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Kashish Goel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: kashish.goel@vumc.org. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Heart Valve Prosthesis Implantation, Mitral Valve, Cardiac Catheterization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Edwards Lifesciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyHeart Valve Prosthesis ImplantationMitral ValveCardiac CatheterizationMitral Valve InsufficiencyTricuspid ValveHumansMaleFemaleTime FactorsTreatment OutcomeAgedRegistriesRisk FactorsSeverity of Illness IndexRisk AssessmentAged, 80 and overHeart Valve ProsthesisRetrospective StudiesUnited StatesRecovery of FunctionMiddle Aged

Stichwörter der Autor:innen

3-yearHF hospitalizationsmitral valve-in-valvemortalitytricuspid regurgitation

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: kashish.goel@vumc.org.
  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Piedmont Hospital, Atlanta, Georgia, USA.
  • Columbia University Medical Center, New York, New York, USA.
  • Mayo Clinic, Rochester, Minnesota, USA.
  • Oregon Health & Science University Hospital, Portland, Oregon, USA.

Förderung

  • Edwards Lifesciences

Zitieren

APA

Goel, K., Lindenfeld, J., Yadav, P., Hahn, R. T., Guerrero, M. E., Chadderdon, S., Sharma, R. P., Smith, R., Thourani, V., Eleid, M. F., Davidson, C. J., Barker, C., Kodali, S., & Zahr, F. (2025). Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.04.034

Vancouver

Goel K, Lindenfeld J, Yadav P, Hahn RT, Guerrero ME, Chadderdon S, et al. Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.04.034

BibTeX
@article{Goel2025,
  author = {Goel, Kashish and Lindenfeld, JoAnn and Yadav, Pradeep and Hahn, Rebecca T and Guerrero, Mayra E and Chadderdon, Scott and Sharma, Rahul P and Smith, Robert and Thourani, Vinod and Eleid, Mackram F and Davidson, Charles J and Barker, Colin and Kodali, Susheel and Zahr, Firas},
  title = {Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.04.034}
}
Kostenlos starten →